Related Experiment Video
Updated: Aug 31, 2025

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Severe mucosal leishmaniasis with torpid and fatal evolution
1Faculty of Health Universidad Privada del Norte Lima Peru.
Mucosal leishmaniasis presents a diagnostic and treatment challenge, often following cutaneous leishmaniasis. This case highlights a severe, neglected progression leading to fatal sepsis.
Area of Science:
- Infectious Diseases
- Dermatology
- Parasitology
Background:
- Mucosal leishmaniasis is a severe manifestation of Leishmania infection.
- It often follows cutaneous leishmaniasis with a significant latency period.
- Diagnosis and treatment can be challenging, leading to potential complications.
Observation:
- A patient with a history of untreated cutaneous leishmaniasis developed severe mucosal leishmaniasis.
- The condition evolved over 9 months, causing facial necrosis, eyeball destruction, and nasal bone exposure.
- The patient presented with chronic anemia, lymphopenia, and neutrophilia.
Findings:
- The patient had co-infections with fungi (yeasts and hyphae) and multidrug-resistant Gram-negative bacteria (Proteus mirabilis, Escherichia coli).
- These co-infections led to sepsis.
- Despite prior incomplete treatment with antimonials and amphotericin B, the disease progressed.
Implications:
- This case underscores the importance of timely and complete treatment for cutaneous leishmaniasis to prevent mucosal progression.
- Highlights the critical role of managing co-infections in immunocompromised patients.
- Emphasizes the potential for severe morbidity and mortality in neglected leishmaniasis cases.
More Related Videos
06:57In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
10:01Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
Published on: March 16, 2018
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Fungal Phylum Microsporidia
Endocarditis II: Clinical Features of Infective Endocarditis